Sara Colombetti, PhDHead of Translational Pharmacology, Roche Oncology pRED at F. Hoffmann-La Roche AGSpeaker
Profile
In 2004 I received my Ph.D. in Molecular and Cellular biology at the San Raffaele Scientific Institute in Milan (Italy). After a post-doc in cancer immunotherapy at the Ludwig Institute for Cancer Research (Lausanne branch) and later at Cytos Biotechnology (Zurich) I have joined the Roche Innovation Center Zurich (RICZ) in 2009, where I initially led the In Vivo Models team and then the Immuno-Pharmacodynamics and PK Unit. In 2018 I have been appointed Global Head of Oncology Discovery Pharmacology, and more recently Head of Translational Pharmacology, part of the Oncology Discovery Unit within the Roche pharma Research and Development (pRED) division. The focus of the group is the development of cutting edge preclinical models for the evaluation of all pRED Oncology portfolio assets.